Page last updated: 2024-09-03

vadimezan and 2-bromopalmitate

vadimezan has been researched along with 2-bromopalmitate in 1 studies

Compound Research Comparison

Studies
(vadimezan)
Trials
(vadimezan)
Recent Studies (post-2010)
(vadimezan)
Studies
(2-bromopalmitate)
Trials
(2-bromopalmitate)
Recent Studies (post-2010) (2-bromopalmitate)
27216101139053

Protein Interaction Comparison

ProteinTaxonomyvadimezan (IC50)2-bromopalmitate (IC50)
Palmitoyltransferase ZDHHC2Homo sapiens (human)2.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akiba, T; Arai, H; Barber, GN; Kobayashi, T; Konno, H; Mukai, K; Taguchi, T; Uemura, T; Waguri, S1

Other Studies

1 other study(ies) available for vadimezan and 2-bromopalmitate

ArticleYear
Activation of STING requires palmitoylation at the Golgi.
    Nature communications, 2016, 06-21, Volume: 7

    Topics: Animals; Chlorocebus aethiops; COS Cells; Embryo, Mammalian; Endoplasmic Reticulum; Fibroblasts; Gene Expression Regulation; Golgi Apparatus; HEK293 Cells; Herpesvirus 1, Human; Humans; Immunity, Innate; Interferon Type I; Lipoylation; Membrane Proteins; Mice; Mutation; Palmitates; Primary Cell Culture; Protein Serine-Threonine Kinases; Protein Transport; Xanthones

2016